000 | 01472 a2200457 4500 | ||
---|---|---|---|
005 | 20250511200812.0 | ||
264 | 0 | _c19920610 | |
008 | 199206s 0 0 eng d | ||
022 | _a0332-5652 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRosenqvist, E | |
245 | 0 | 0 |
_aHuman antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies. _h[electronic resource] |
260 |
_bNIPH annals _cDec 1991 |
||
300 |
_a169-79; discussion 180-1 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
650 | 0 | 4 | _aAntibody Formation |
650 | 0 | 4 | _aBacterial Capsules |
650 | 0 | 4 |
_aBacterial Outer Membrane Proteins _ximmunology |
650 | 0 | 4 |
_aBacterial Vaccines _xchemistry |
650 | 0 | 4 |
_aCarrier Proteins _xblood |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 |
_aImmunoglobulin M _xblood |
650 | 0 | 4 | _aMeningococcal Vaccines |
650 | 0 | 4 | _aNorway |
650 | 0 | 4 |
_aPolysaccharides, Bacterial _ximmunology |
700 | 1 | _aHøiby, E A | |
700 | 1 | _aBjune, G | |
700 | 1 | _aBryn, K | |
700 | 1 | _aCloss, O | |
700 | 1 | _aFeiring, B | |
700 | 1 | _aKlem, A | |
700 | 1 | _aNøkleby, H | |
700 | 1 | _aFrølm, L O | |
773 | 0 |
_tNIPH annals _gvol. 14 _gno. 2 _gp. 169-79; discussion 180-1 |
|
999 |
_c1693882 _d1693882 |